Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia
· Delayed Price · Currency is MYR 0.2450
-0.0050 (-2.00%)
At close: May 28, 2025
Pharmaniaga Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 135.76 | 131.82 | -80.16 | -629.92 | 172.15 | 27.49 | Upgrade
|
| Depreciation & Amortization | 37.81 | 38.35 | 38.77 | 34.02 | 31.7 | 30.76 | Upgrade
|
| Other Amortization | 4.31 | 3.03 | 2.93 | 2.41 | 1.68 | 1.58 | Upgrade
|
| Other Operating Activities | -57.62 | -130.53 | 85.41 | 451.15 | -269.58 | -85.54 | Upgrade
|
| Operating Cash Flow | 120.26 | 42.67 | 46.95 | -142.34 | -64.06 | -25.71 | Upgrade
|
| Operating Cash Flow Growth | 110.25% | -9.12% | - | - | - | - | Upgrade
|
| Capital Expenditures | -27.75 | -31.16 | -50.67 | -59.26 | -30.39 | -9.25 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.13 | 0.08 | 1.32 | 0.06 | 0.21 | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | -7.69 | -8.41 | -10.34 | -18.38 | -14.97 | -23.38 | Upgrade
|
| Other Investing Activities | 0.41 | -6.13 | -8.24 | 5.25 | -0.41 | - | Upgrade
|
| Investing Cash Flow | -34.9 | -45.62 | -67.93 | -72.34 | -45.56 | -32.64 | Upgrade
|
| Short-Term Debt Issued | - | - | 50 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 2,150 | 3,248 | 2,291 | 2,329 | 1,541 | Upgrade
|
| Total Debt Issued | 2,125 | 2,150 | 3,298 | 2,291 | 2,329 | 1,541 | Upgrade
|
| Long-Term Debt Repaid | - | -2,139 | -3,240 | -1,988 | -2,149 | -1,443 | Upgrade
|
| Total Debt Repaid | -2,169 | -2,139 | -3,240 | -1,988 | -2,149 | -1,443 | Upgrade
|
| Net Debt Issued (Repaid) | -44.04 | 10.67 | 57.48 | 303.42 | 179.73 | 97.72 | Upgrade
|
| Issuance of Common Stock | - | - | 45.86 | - | - | - | Upgrade
|
| Common Dividends Paid | - | - | -7.86 | -82.53 | -58.95 | -26.14 | Upgrade
|
| Other Financing Activities | 11.43 | 11.43 | -0.21 | -0.1 | -0.04 | -0.09 | Upgrade
|
| Financing Cash Flow | -32.61 | 22.1 | 95.27 | 220.79 | 120.74 | 71.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.73 | -0.52 | 0.31 | -0.39 | 0.13 | -0.23 | Upgrade
|
| Net Cash Flow | 52.02 | 18.64 | 74.59 | 5.74 | 11.25 | 12.91 | Upgrade
|
| Free Cash Flow | 92.51 | 11.51 | -3.72 | -201.6 | -94.44 | -34.96 | Upgrade
|
| Free Cash Flow Margin | 2.40% | 0.31% | -0.11% | -5.79% | -1.96% | -1.28% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.01 | -0.00 | -0.15 | -0.07 | -0.03 | Upgrade
|
| Cash Interest Paid | 68.17 | 68.11 | 60.81 | 41.29 | 32.63 | 38.57 | Upgrade
|
| Cash Income Tax Paid | 40.2 | 33.89 | 20.56 | 39.52 | 39.7 | 2.94 | Upgrade
|
| Levered Free Cash Flow | 85.92 | -16.53 | 31.75 | 479.12 | -143.76 | -75.73 | Upgrade
|
| Unlevered Free Cash Flow | 130.84 | 28.45 | 70.4 | 504.15 | -122.93 | -54.67 | Upgrade
|
| Change in Net Working Capital | 42.03 | 136.44 | -102.48 | -525.76 | 304.8 | 97.56 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.